Result of AGM and Transaction Update
Source: RNS24 December 2025
Beacon Energy plc
("Beacon Energy" or the "Company")
Result of AGM and Transaction Update
Beacon Energy plc (AIM:BCE), is pleased to announce that at the Company's Annual General Meeting held earlier today, all resolutions were duly passed.
In addition, further to the Company's announcement on 7 October 2025, the Company is pleased to confirm that the Proposed Transaction is progressing well with an Admission Document expected to be published in January 2026 and Completion of the Proposed Transaction shortly thereafter.
In order to preserve cash and fund certain costs prior to Completion of the Proposed Transaction, Stewart MacDonald (CEO), Mark Rollins (Chairman) and Leo Koot (Non-executive Director) have each agreed to defer 100% of their fees until Completion of the Proposed Transaction. In addition, Mark Rollins and Leo Koot have each agreed to provide a £25,000 short-term unsecured interest-free loan to the Company (the "Directors' Loan").
Related Party Transaction
Mark Rollins and Leo Koot are directors of the Company, and accordingly the Directors' Loan constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies.
The independent directors of the Company for the purpose of the Directors' Loan, being Stewart MacDonald and Ross Warner, having consulted with the Company's Nominated Adviser, Strand Hanson Limited, consider the terms the Directors' Loan to be fair and reasonable insofar as the Shareholders are concerned.
For further information, please visit https://beaconenergyplc.com/ or the following:
|
|
||||||||||
|
|
|
|
||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.